Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks
Clinical trial NCT01188564 · COMPLETED
Trial details
- NCT number
- NCT01188564
- Sponsor
- Pharming Technologies B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-12-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.